These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 17113046

  • 1. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
    Ba M, Kong M, Ma G, Yang H, Lu G, Chen S, Liu Z.
    Brain Res; 2007 Jan 05; 1127(1):177-84. PubMed ID: 17113046
    [Abstract] [Full Text] [Related]

  • 2. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects.
    Carey RJ, DePalma G, Damianopoulos E, Shanahan A, Müller CP, Huston JP.
    Brain Res; 2005 Feb 09; 1034(1-2):162-71. PubMed ID: 15713268
    [Abstract] [Full Text] [Related]

  • 3. A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson's disease.
    Tomiyama M, Kimura T, Maeda T, Kannari K, Matsunaga M, Baba M.
    Neurosci Res; 2005 Jun 09; 52(2):185-94. PubMed ID: 15893579
    [Abstract] [Full Text] [Related]

  • 4. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment.
    Santucci AC, Madeira E.
    Brain Res Bull; 2008 Jul 01; 76(4):402-11. PubMed ID: 18502317
    [Abstract] [Full Text] [Related]

  • 5. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability.
    Iravani MM, Tayarani-Binazir K, Chu WB, Jackson MJ, Jenner P.
    J Pharmacol Exp Ther; 2006 Dec 01; 319(3):1225-34. PubMed ID: 16959959
    [Abstract] [Full Text] [Related]

  • 6. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
    Guenther U, Manzke T, Wrigge H, Dutschmann M, Zinserling J, Putensen C, Hoeft A.
    Anesth Analg; 2009 Apr 01; 108(4):1169-76. PubMed ID: 19299781
    [Abstract] [Full Text] [Related]

  • 7. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
    Batool F, Haleem DJ.
    Pak J Pharm Sci; 2008 Oct 01; 21(4):411-20. PubMed ID: 18930864
    [Abstract] [Full Text] [Related]

  • 8. Activation of septal 5-HT1A receptors alters spatial memory encoding, interferes with consolidation, but does not affect retrieval in rats subjected to a water-maze task.
    Koenig J, Cosquer B, Cassel JC.
    Hippocampus; 2008 Oct 01; 18(1):99-118. PubMed ID: 17924524
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I, Johansson C, Ogren SO.
    Br J Pharmacol; 1998 Oct 01; 125(3):499-509. PubMed ID: 9806333
    [Abstract] [Full Text] [Related]

  • 10. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation.
    Gogos A, Kusljic S, van den Buuse M.
    Pharmacol Biochem Behav; 2005 Jul 01; 81(3):664-72. PubMed ID: 15955549
    [Abstract] [Full Text] [Related]

  • 11. The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization.
    Ramos AJ, Rubio MD, Defagot C, Hischberg L, Villar MJ, Brusco A.
    Brain Res; 2004 Dec 31; 1030(2):201-20. PubMed ID: 15571670
    [Abstract] [Full Text] [Related]

  • 12. 5-HT1A receptor activation before acute stress counteracted the induced long-term behavioral effects.
    Rioja J, Santín LJ, García M, Doña A, De Pablos L, Cuadrado MI, Alcalde FJ, González-Barón S, Aguirre JA.
    Ann N Y Acad Sci; 2004 Jun 31; 1018():333-8. PubMed ID: 15240387
    [Abstract] [Full Text] [Related]

  • 13. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization.
    Zimmer L, Riad M, Rbah L, Belkacem-Kahlouli A, Le Bars D, Renaud B, Descarries L.
    Neuroimage; 2004 Jul 31; 22(3):1421-6. PubMed ID: 15219613
    [Abstract] [Full Text] [Related]

  • 14. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.
    Bermack JE, Debonnel G.
    J Psychopharmacol; 2007 Jan 31; 21(1):85-92. PubMed ID: 16533864
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.
    Lüttgen M, Elvander E, Madjid N, Ogren SO.
    Neuropharmacology; 2005 May 31; 48(6):830-52. PubMed ID: 15829255
    [Abstract] [Full Text] [Related]

  • 16. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.
    Iderberg H, Rylander D, Bimpisidis Z, Cenci MA.
    Exp Neurol; 2013 Dec 31; 250():116-24. PubMed ID: 24029003
    [Abstract] [Full Text] [Related]

  • 17. 8-OH-DPAT prevents morphine-induced apoptosis in rat dorsal raphe nucleus: a possible mechanism for attenuating morphine tolerance.
    Charkhpour M, Nayebi AR, Doustar Y, Hassanzadeh K.
    Anesth Analg; 2010 Nov 31; 111(5):1316-21. PubMed ID: 20736434
    [Abstract] [Full Text] [Related]

  • 18. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec 31; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

  • 19. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 31; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

  • 20. 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors.
    Ebenezer IS, Arkle MJ, Tite RM.
    Methods Find Exp Clin Pharmacol; 2007 May 31; 29(4):269-72. PubMed ID: 17609739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.